87 related articles for article (PubMed ID: 6523641)
1. Natural killer cell activity in patients with prostatic carcinoma and its in vivo boosting with bacillus Calmette-Guérin.
Schwemmer B; Lehmer A; Hofmann R; Braun J
Urol Int; 1984; 39(6):321-6. PubMed ID: 6523641
[TBL] [Abstract][Full Text] [Related]
2. Activation of natural killer cells by Bacillus Calmette-Guérin.
Brandau S; Böhle A
Eur Urol; 2001 May; 39(5):518-24. PubMed ID: 11464031
[TBL] [Abstract][Full Text] [Related]
3. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
4. Development of bacillus Calmette-Guérin-induced antitumor activity in peripheral blood mononuclear cells.
Koga S; Taniguchi K; Nishikido M; Kubota S; Yamashita S; Kanetake H; Saito Y
Urol Int; 1991; 47 Suppl 1():80-2. PubMed ID: 1949386
[TBL] [Abstract][Full Text] [Related]
5. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
[TBL] [Abstract][Full Text] [Related]
6. Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG.
Mandeville R; Sombo FM; Rocheleau N
Cancer Immunol Immunother; 1983; 15(1):17-22. PubMed ID: 6553503
[TBL] [Abstract][Full Text] [Related]
7. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
Arends-Merino A; Sjögren AM; Reizenstein P
Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant immunotherapy with bacillus Calmette-Guérin in prostatic cancer.
Guinan P; Crispen R; Baumgartner G; Rao R; Totonchi E; Ablin R; John T
Urology; 1979 Dec; 14(6):561-5. PubMed ID: 390811
[TBL] [Abstract][Full Text] [Related]
10. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
Marras F; Bozzano F; Bentivoglio G; Ugolotti E; Biassoni R; Moretta L; De Maria A
Eur J Immunol; 2012 Sep; 42(9):2459-70. PubMed ID: 22736333
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
[TBL] [Abstract][Full Text] [Related]
12. Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
Kawahara M; Hasegawa N; Takaku H
PLoS One; 2016; 11(3):e0152051. PubMed ID: 26999357
[TBL] [Abstract][Full Text] [Related]
13. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of natural killer cells in carcinoma of the prostate.
Wirth M; Schmitz-Dräger BJ; Ackermann R
J Urol; 1985 Jun; 133(6):973-8. PubMed ID: 3999223
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
Kaasinen ES; Harju LM; Timonen TT
J Urol; 2002 May; 167(5):2209-14. PubMed ID: 11956480
[TBL] [Abstract][Full Text] [Related]
16. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?
Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Shapiro A
BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate.
Marumo K; Ikeuchi K; Baba S; Ueno M; Tazaki H
Keio J Med; 1989 Mar; 38(1):27-35. PubMed ID: 2716216
[TBL] [Abstract][Full Text] [Related]
18. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
Yutkin V; Pode D; Pikarsky E; Mandelboim O
J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the activity of natural killer cells in superficial bladder cancer during intravesical BCG therapy].
Samodai L; Dankó K
Orv Hetil; 1992 Sep; 133(36):2283-6, 2291-2. PubMed ID: 1408062
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C
J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
